Skip to main content

University of California San Francisco
UCSF Health
Search UCSF
About UCSF

Precision Medicine at UCSF

Search form

Search...

About
The Elements of Precision Medicine
Programs
Projects
News & Events
Resources
- UCSF Centers & Affiliates
- Funding Opportunities

You are here

Home > Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): a Therapeutic Advances in Childhood Leukemia (TACL) Consortium study.

Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): a Therapeutic Advances in Childhood Leukemia (TACL) Consortium study.

Filter Scientific Publications

By Date

By Date

Date

E.g., 04-24

By Date

Date

E.g., 04-24

Scientific Area

Follow @UCSFPrecision

precisionmedicine.ucsf.edu

Accessibility
Privacy Policy
Terms of Use
A-Z Website List

© 2024 The Regents of the University of California